Sökning: onr:"swepub:oai:gup.ub.gu.se/55672" >
The dopaminergic st...
The dopaminergic stabiliser ACR16 counteracts the behavioural primitivization induced by the NMDA receptor antagonist MK-801 in mice: implications for cognition
-
- Nilsson, Marie, 1968 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap,Institute of Clinical Neurosciences
-
Carlsson, Arvid, 1923 (författare)
-
Rydén Markinhuhta, K (författare)
-
visa fler...
-
Sonesson, C. (författare)
-
Pettersson, F. (författare)
-
Gullme, M. (författare)
-
- Carlsson, Maria L., 1959 (författare)
- Gothenburg University,Göteborgs universitet,Institutionen för klinisk neurovetenskap,Institute of Clinical Neurosciences
-
visa färre...
-
(creator_code:org_t)
- Elsevier BV, 2004
- 2004
- Engelska.
-
Ingår i: Prog Neuropsychopharmacol Biol Psychiatry. - : Elsevier BV. - 0278-5846. ; 28:4, s. 677-85
- Relaterad länk:
-
https://gup.ub.gu.se...
-
visa fler...
-
https://doi.org/10.1...
-
visa färre...
Abstract
Ämnesord
Stäng
- The Carlsson research group has developed a series of compounds capable of stabilising the dopamine system without inducing the deleterious hypodopaminergia that encumbers the currently used antipsychotic drugs. In the present study one of these dopaminergic stabilisers, ACR16, was tested in a mouse model for cognitive deficits of schizophrenia and autism. Since we believe that hypoglutamatergia is a key element in both schizophrenia and autism we used mice rendered hypoglutamatergic by treatment with the N-methyl-D-aspartate (NMDA) antagonist MK-801. MK-801 causes both hyperactivity and a behavioural primitivization. ACR16 attenuated the MK-801-induced hyperactivity and, in addition, caused a marked improvement of behavioural quality with a movement pattern approaching that of control animals. Since we believe that the impoverishment of the behavioural repertoire caused by MK-801 may correspond to the cognitive deficits seen in schizophrenia and autism, these results suggest that ACR16 may improve cognitive status in these disorders.
Ämnesord
- MEDICIN OCH HÄLSOVETENSKAP -- Medicinska och farmaceutiska grundvetenskaper -- Farmakologi och toxikologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Basic Medicine -- Pharmacology and Toxicology (hsv//eng)
Nyckelord
- Animals
- Autistic Disorder/chemically induced/psychology
- Behavior
- Animal/*drug effects
- Cognition/*drug effects
- Dizocilpine Maleate/*antagonists & inhibitors/*pharmacology
- Dopamine Antagonists/*pharmacology
- Dose-Response Relationship
- Drug
- Excitatory Amino Acid Antagonists/*pharmacology
- Glutamic Acid/deficiency
- Grooming/drug effects
- Haloperidol/pharmacology
- Hyperkinesis/chemically induced/prevention & control
- Male
- Mice
- Motor Activity/drug effects
- Piperidines/*pharmacology
- Receptors
- Dopamine D2/antagonists & inhibitors
- Schizophrenia/chemically induced
Publikations- och innehållstyp
- ref (ämneskategori)
- art (ämneskategori)
Hitta via bibliotek
Till lärosätets databas